Report Search Results (Showing 1 to 20 of 45)	As of 21-Nov-2009
New Screen

All Reports | Brokerage Reports | Independent Reports

Release Date  Contributor Author Title Pages Price StarMine Author Rating More Info EPS Accuracy * Portfolio Return ** 12-Nov-09 Brean Murray & Co., Inc. Jonathan M. Aschoff PhD KERX: Updates Perifosine Results In Multiple Myeloma - Still Positive 5 $10     View Abstract 12-Nov-09 Brean Murray & Co., Inc. Jonathan M. Aschoff PhD DNDN: Reports 3Q09 Results 4 $10     View Abstract 12-Nov-09 Brean Murray & Co., Inc. Jonathan M. Aschoff PhD, Ryan Worst CFA, Andrey Glukhov CFA, Daniel Fidell Morning Insight (CAST, KONG, CHDN, DNDN, KERX, ATO) 9 $25     View Abstract 11-Nov-09 Brean Murray & Co., Inc. Jonathan M. Aschoff PhD, Andrey Glukhov CFA, Bret Jones Morning Insight (ATVI, ERTS, THQI, TTWO, EM, BEBE, GES, JCG, TRLG) 6 $25     View Abstract 10-Nov-09 Brean Murray & Co., Inc. Jonathan M. Aschoff PhD KERX: Reports 3Q09 Results 4 $10     View Abstract 10-Nov-09 Brean Murray & Co., Inc. Jonathan M. Aschoff PhD MIPI: Reports 3Q09 Results – Full Clinical Plate 4 $10     View Abstract 10-Nov-09 Brean Murray & Co., Inc. Jonathan M. Aschoff PhD HYTM: Reports 3Q09 Results 4 $10     View Abstract 10-Nov-09 Brean Murray & Co., Inc. Jonathan M. Aschoff PhD, Andrey Glukhov CFA, Michael Gaugler, Daniel Fidell, Jose Haresco, Bret Jones Morning Insight (ERTS, GAME, NTES, PWRD, SNDA, MIPI, HYTM, HOLX, QSII, COMV, SWWC) 10 $25     View Abstract 9-Nov-09 Brean Murray & Co., Inc. Jonathan M. Aschoff PhD HALO: Reports Positive Insulin Results 4 $10     View Abstract 9-Nov-09 Brean Murray & Co., Inc. Jonathan M. Aschoff PhD PGNX: Reports 3Q09 Results 4 $10     View Abstract 9-Nov-09 Brean Murray & Co., Inc. Jonathan M. Aschoff PhD CYTR: Reports 3Q09 Results 4 $10     View Abstract 6-Nov-09 Brean Murray & Co., Inc. Jonathan M. Aschoff PhD HALO: Reports 3Q09 Results 4 $10     View Abstract 5-Nov-09 Brean Murray & Co., Inc. Jonathan M. Aschoff PhD CNSO: Treatment Resistant Depression Trial Yields Positive Results 5 $10     View Abstract 5-Nov-09 Brean Murray & Co., Inc. Jonathan M. Aschoff PhD NKTR: Reports 3Q09 Results – Expecting Positive NKTR-102 Data 4 $10     View Abstract 5-Nov-09 Brean Murray & Co., Inc. Jonathan M. Aschoff PhD SGMO: Reports 3Q09 Results – Expecting Phase 2 Failure in ALS 4 $10     View Abstract 5-Nov-09 Brean Murray & Co., Inc. Jonathan M. Aschoff PhD MDVN: Reports 3Q09 Results – Expecting Connection Trial to Fail In 1H10 4 $10     View Abstract 5-Nov-09 Brean Murray & Co., Inc. Eric M. Beder, Jonathan M. Aschoff PhD, Andrey Glukhov CFA, Michael Gaugler, Daniel Fidell, Jose Haresco, Bret Jones Morning Insight (AWR, WRC, AMMD, PFWD, NKTR, CNSO, MDVN, SGMO, ELON, CHG, CNP, NST, NU, UIL, UTL, VVC, THQI) 16 $50     View Abstract 4-Nov-09 Brean Murray & Co., Inc. Jonathan M. Aschoff PhD CLDX: Reports 3Q09 Results – All Clinical Programs on Track 5 $10     View Abstract 4-Nov-09 Brean Murray & Co., Inc. Jonathan M. Aschoff PhD PARD: Reports 3Q09 Results – Pivotal Results Coming Within Weeks 4 $10     View Abstract 4-Nov-09 Brean Murray & Co., Inc. Eric M. Beder, Jonathan M. Aschoff PhD, Michael Gaugler, Jose Haresco, Ling Wang CFA, Ananda Baruah, Jeremy Sussman Morning Insight (ANR, JRCC, PBI, MWA, TRLG, AEO, ANF, ARO, URBN, VOLC, ARIA, PARD) 11 $25     View Abstract Next 20